Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression.
Albring JC, Sandau MM, Rapaport AS, Edelson BT, Satpathy A, Mashayekhi M, Lathrop SK, Hsieh CS, Stelljes M, Colonna M, et al. J Exp Med. 2010 Nov 22; 207(12):2551-9. Epub 2010 Nov 15.